Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Efficacy of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension
NCT00332436Phase 3Completed
- Sponsor
- Allergan
- Start
- Dec 1999
- Primary completion
- Nov 2001
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brimonidine tartrate + timolol maleate in Glaucoma and ocular hypertension (3 arms), sponsored by Allergan. Primary endpoint: Intraocular Pressure at 12 months. Started Dec 1999; status: completed.
02
Drugs
brimonidine tartrate + timolol maleate
03
Conditions
Glaucomaocular hypertension
Beyond the preview
Go deeper on NCT00332436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00332436.